Pro-Dex Inc (PDEX)
48.48
+1.52
(+3.24%)
USD |
NASDAQ |
Nov 14, 16:00
48.48
0.00 (0.00%)
After-Hours: 20:00
Pro-Dex Revenue (Quarterly): 14.89M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 14.89M |
June 30, 2024 | 15.02M |
March 31, 2024 | 14.29M |
December 31, 2023 | 12.59M |
September 30, 2023 | 11.94M |
June 30, 2023 | 10.64M |
March 31, 2023 | 13.08M |
December 31, 2022 | 11.28M |
September 30, 2022 | 11.09M |
June 30, 2022 | 12.62M |
March 31, 2022 | 9.265M |
December 31, 2021 | 10.17M |
September 30, 2021 | 9.988M |
June 30, 2021 | 9.435M |
March 31, 2021 | 11.74M |
December 31, 2020 | 8.265M |
September 30, 2020 | 8.59M |
June 30, 2020 | 11.12M |
March 31, 2020 | 8.508M |
December 31, 2019 | 7.961M |
September 30, 2019 | 7.24M |
June 30, 2019 | 7.004M |
March 31, 2019 | 6.854M |
December 31, 2018 | 6.399M |
September 30, 2018 | 6.916M |
Date | Value |
---|---|
June 30, 2018 | 6.248M |
March 31, 2018 | 5.494M |
December 31, 2017 | 5.56M |
September 30, 2017 | 5.162M |
June 30, 2017 | 5.597M |
March 31, 2017 | 6.618M |
December 31, 2016 | 4.599M |
September 30, 2016 | 5.129M |
June 30, 2016 | 4.99M |
March 31, 2016 | 5.176M |
December 31, 2015 | 5.231M |
September 30, 2015 | 4.097M |
June 30, 2015 | 4.073M |
March 31, 2015 | 3.922M |
December 31, 2014 | 2.792M |
September 30, 2014 | 2.595M |
June 30, 2014 | 3.213M |
March 31, 2014 | 2.404M |
December 31, 2013 | 2.64M |
September 30, 2013 | 2.555M |
June 30, 2013 | 2.722M |
March 31, 2013 | 3.06M |
December 31, 2012 | 3.007M |
September 30, 2012 | 3.461M |
June 30, 2012 | 3.656M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
7.961M
Minimum
Dec 2019
15.02M
Maximum
Jun 2024
11.12M
Average
11.11M
Median
Revenue (Quarterly) Benchmarks
Perspective Therapeutics Inc | -- |
Retractable Technologies Inc | 6.029M |
InfuSystems Holdings Inc | 35.32M |
Xtant Medical Holdings Inc | 29.94M |
Catheter Precision Inc | 0.093M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | 2.466M |
Total Expenses (Quarterly) | 11.88M |
EPS Diluted (Quarterly) | 0.75 |
Enterprise Value | 158.72M |
Gross Profit Margin (Quarterly) | 34.58% |
Profit Margin (Quarterly) | 16.56% |
Earnings Yield | 3.16% |
Operating Earnings Yield | 4.96% |
Normalized Earnings Yield | 3.642 |